Levocetirizine Krka

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Krka, is a second‑generation antihistamine presented as an oral dosage form for oral use. It is employed to alleviate symptoms of allergic rhinitis and to manage chronic idiopathic urticaria in adults and adolescents. It offers a non‑sedating option and conforms to EU‑approved pharmaceutical standards.

GNH USA supplies Levocetirizine Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance and regulatory compliance across all markets, with reliable logistics and dedicated customer support.

Levocetirizine Krka, a second‑generation antihistamine, is used to treat allergic conditions by blocking peripheral H1 receptors.

- Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: provides symptom relief during pollen exposure periods. - Chronic idiopathic urticaria: decreases the frequency and severity of hives and associated itching.

Levocetirizine Krka may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: mild sleepiness reported by some patients. - Headache: transient cranial discomfort. - Dry mouth: reduced salivary flow. - Fatigue: general lack of energy. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue requiring urgent care. - Anaphylaxis: severe allergic reaction with possible respiratory compromise. - Stevens‑Johnson syndrome: rare skin blistering condition. - Thrombocytopenia: low platelet count observed in isolated cases. - Cardiac arrhythmia: irregular heartbeat reported infrequently.

Before prescribing Levocetirizine Krka, clinicians should consider several precautionary measures to ensure patient safety. - Pregnancy: assess risk‑benefit and consult obstetric guidance. - Breastfeeding: monitor infant for possible sedation or allergic reactions. - Renal impairment: dose adjustment may be required in severe dysfunction. - Concomitant CNS depressants: avoid additive sedation when combined with alcohol or sedatives. - Elderly patients: start with lowest effective dose and monitor for side effects. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Levocetirizine Krka can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Alcohol: may enhance sedative effects. - Other H1 antihistamines: additive antihistaminic activity can increase drowsiness. - Ketoconazole: strong CYP3A4 inhibition may raise levocetirizine plasma levels.

Moderate Interactions (Monitor Closely): - Erythromycin: moderate CYP3A4 inhibitor that can modestly increase drug exposure. - Cimetidine: may reduce renal clearance, leading to higher concentrations. - Theophylline: potential for increased theophylline levels. - Ritonavir: may elevate levocetirizine concentrations.